<DOC>
	<DOCNO>NCT01299688</DOCNO>
	<brief_summary>The investigator propose survey frequency HER2 ( + ) CTC order lay groundwork future clinical trial incorporate Her-2 targeted agent gastric cancer .</brief_summary>
	<brief_title>HER2 Circulating Tumor Cells Gastric Cancer</brief_title>
	<detailed_description>We propose survey frequency HER2 ( + ) CTC order lay groundwork future clinical trial incorporate Her-2 targeted agent gastric cancer . Blood sample collect metastatic gastric cancer patient .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Patients older 18 year ② Patients localize , histologically confirm gastric cancer ③ Informed consent form No informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>